Dianthus Therapeutics 

€91.00
0
+€4.00+4.6% Thursday 09:35

Statistics

Day High
91
Day Low
91
52W High
91
52W Low
70
Volume
29
Avg. Volume
-
Mkt Cap
4.97B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q1 2026
Next
-0.91
-0.85
-0.79
-0.73
Expected EPS
-0.7397368444
Actual EPS
N/A

Financials

-7,719.33%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.82MRevenue
-140.35MNet Income

Analyst Ratings

95.82Average Price Target
The highest estimate is 151.76.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 87E.XETRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Show more...
CEO
ISIN
US2528281080
WKN
000A3ERZ4

Listings

0 Comments

Share your thoughts

FAQ

What is Dianthus Therapeutics stock price today?
The current price of 87E.XETRA is €91.00 EUR — it has increased by +4.6% in the past 24 hours. Watch Dianthus Therapeutics stock price performance more closely on the chart.
What is Dianthus Therapeutics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange Dianthus Therapeutics stocks are traded under the ticker 87E.XETRA.
What is Dianthus Therapeutics market cap?
Today Dianthus Therapeutics has the market capitalization of 4.97B
When is the next Dianthus Therapeutics earnings date?
Dianthus Therapeutics is going to release the next earnings report on August 06, 2026.
What were Dianthus Therapeutics earnings last quarter?
87E.XETRA earnings for the last quarter are -0.73 EUR per share, whereas the estimation was -0.91 EUR resulting in a +20.7% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Dianthus Therapeutics revenue for the last year?
Dianthus Therapeutics revenue for the last year amounts to 1.82M EUR.
What is Dianthus Therapeutics net income for the last year?
87E.XETRA net income for the last year is -140.35M EUR.
In which sector is Dianthus Therapeutics located?
Dianthus Therapeutics operates in the Other sector.
When did Dianthus Therapeutics complete a stock split?
Dianthus Therapeutics has not had any recent stock splits.